Immunotherapy drug used as 1st-line therapy for Merkel cell carcinoma improved survival
Credit: LSU Health New Orleans New Orleans, LA - A multi-center phase II clinical trial investigating pembrolizumab as a first-line and programmed cell death-1 therapy...








